A Phase II Trial of Xevinapant in Combination with Post-Operative Cisplatin and Radiotherapy for High Risk Head and Neck Cancer
International Journal of Radiation OncologyBiologyPhysics（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
International Journal of Radiation OncologyBiologyPhysics（2024）